Association of miRNA-146a Gene Polymorphism Rs2910164 with Behcet’s Disease: A Meta-analysis

References

• Sakane T, Takeno M, Suzuki N, Inaba G. Behcet’s disease. N Engl J Med. 1999;341:1284–1291. doi:10.1056/NEJM199910213411707.
   PubMed Web of Science ®Google Scholar
• Hatemi G, Silman A, Bang D, et al. EULAR recommendations for the management of Behcet disease. Ann Rheum Dis. 2008;67:1656–1662. doi:10.1136/ard.2007.080432.
   PubMed Web of Science ®Google Scholar
• Bettiol A, Prisco D, Emmi G. Behcet: the syndrome. Rheumatology (Oxford). 2020;59:iii101–iii7. doi:10.1093/rheumatology/kez626.
   PubMed Web of Science ®Google Scholar
• Verity DH, Marr JE, Ohno S, Wallace GR, Stanford MR. Behcet’s disease, the Silk Road and HLA-B51: historical and geographical perspectives. Tissue Antigens. 1999;54:213–220. doi:10.1034/j.1399-0039.1999.540301.x.
   PubMed Web of Science ®Google Scholar
• Morton LT, Situnayake D, Wallace GR. Genetics of Behçet’s disease. Curr Opin Rheumatol. 2016;28:39–44. doi:10.1097/BOR.0000000000000234.
   PubMed Web of Science ®Google Scholar
• Giza M, Koftori D, Chen L, Bowness P. Is Behcet’s disease a “class 1-opathy’? The role of HLA-B*51 in the pathogenesis of Behcet’s disease. Clin Exp Immunol. 2018;191:11–18. doi:10.1111/cei.13049.
   PubMed Web of Science ®Google Scholar
• Zhang M, Xu WD, Wen PF, et al. Polymorphisms in the tumor necrosis factor gene and susceptibility to Behcet’s disease: an updated meta-analysis. Mol Vis. 2013;19:1913–1924.
   PubMed Web of Science ®Google Scholar
• Kirino Y, Bertsias G, Ishigatsubo Y, et al. Genome-wide association analysis identifies new susceptibility loci for Behcet’s disease and epistasis between HLA-B*51 and ERAP1. Nat Genet. 2013;45:202–207. doi:10.1038/ng.2520.
   PubMed Web of Science ®Google Scholar
• Remmers EF, Cosan F, Kirino Y, et al. Genome-wide association study identifies variants in the MHC class I, IL10, and IL23R-IL12RB2 regions associated with Behcet’s disease. Nat Genet. 2010;42:698–702. doi:10.1038/ng.625.
   PubMed Web of Science ®Google Scholar
• Mizuki N, Meguro A, Ota M, et al. Genome-wide association studies identify IL23R-IL12RB2 and IL10 as Behcet’s disease susceptibility loci. Nat Genet. 2010;42:703–706. doi:10.1038/ng.624.
   PubMed Web of Science ®Google Scholar
• Kappen JH, Medina-Gomez C, Van Hagen PM, et al. Genome-wide association study in an admixed case series reveals IL12A as a new candidate in Behcet disease. PLoS One. 2015;10:e0119085. doi:10.1371/journal.pone.0119085.
   PubMed Web of Science ®Google Scholar
• Chatzikyriakidou A, Voulgari PV, Georgiou I, Drosos AA. miRNAs and related polymorphisms in rheumatoid arthritis susceptibility. Autoimmun Rev. 2012;11:636–641. doi:10.1016/j.autrev.2011.11.004.
   PubMed Web of Science ®Google Scholar
• Pritchard CC, Cheng HH, Tewari M. MicroRNA profiling: approaches and considerations. Nat Rev Genet. 2012;13:358–369. doi:10.1038/nrg3198.
   PubMed Web of Science ®Google Scholar
• Xu T, Zhu Y, Wei QK, et al. A functional polymorphism in the miR-146a gene is associated with the risk for hepatocellular carcinoma. Carcinogenesis. 2008;29:2126–2131. doi:10.1093/carcin/bgn195.
   PubMed Web of Science ®Google Scholar
• Qi J, Hou S, Zhang Q, et al. A functional variant of pre-miRNA-196a2 confers risk for Behcet’s disease but not for Vogt-Koyanagi-Harada syndrome or AAU in ankylosing spondylitis. Hum Genet. 2013;132:1395–1404. doi:10.1007/s00439-013-1346-8.
   PubMed Web of Science ®Google Scholar
• Yu H, Liu Y, Bai L, Kijlstra A, Yang P. Predisposition to Behçet’s disease and VKH syndrome by genetic variants of miR-182. J Mol Med (Berl). 2014;92:961–967. doi:10.1007/s00109-014-1159-9.
   PubMed Web of Science ®Google Scholar
• Lee SJ, Seo JW, Chae YS, et al. Genetic polymorphism of miR-196a as a prognostic biomarker for early breast cancer. Anticancer Res. 2014;34:2943–2949.
   PubMed Web of Science ®Google Scholar
• Fu B, Song P, Lu M, Wang B, Zhao Q. The association between miR-146a gene rs2910164 polymorphism and gastric cancer risk: a meta-analysis. Biomed Pharmacother. 2014;68:923–928. doi:10.1016/j.biopha.2014.10.002.
   PubMed Web of Science ®Google Scholar
• Gao X, Zhu Z, Zhang S. miR-146a rs2910164 polymorphism and the risk of colorectal cancer in Chinese population. J Cancer Res Ther. 2018;14:S97–S9. doi:10.4103/0973-1482.165864.
   PubMed Web of Science ®Google Scholar
• Zhang X, He R, Ren F, Tang R, Chen G. Association of miR-146a rs2910164 polymorphism with squamous cell carcinoma risk: a meta-analysis. J BUON. 2015;20:829–841.
   PubMed Web of Science ®Google Scholar
• Zhou Q, Hou S, Liang L, et al. MicroRNA-146a and Ets-1 gene polymorphisms in ocular Behcet’s disease and Vogt-Koyanagi-Harada syndrome. Ann Rheum Dis. 2014;73:170–176. doi:10.1136/annrheumdis-2012-201627.
   PubMed Web of Science ®Google Scholar
• Oner T, Yenmis G, Tombulturk K, et al. Association of Pre-miRNA-499 rs3746444 and Pre-miRNA-146a rs2910164 polymorphisms and susceptibility to Behcet’s Disease. Genet Test Mol Biomarkers. 2015;19:424–430. doi:10.1089/gtmb.2015.0016.
   PubMed Web of Science ®Google Scholar
• Ibrahim W, Sakr BR, Obaya E, Ghonem H. MicroRNA-146a expression and microRNA-146a rs2910164 polymorphism in Behcet’s disease patients. Clin Rheumatol. 2019;38:397–402. doi:10.1007/s10067-018-4191-2.
   PubMed Web of Science ®Google Scholar
• Yenmis G, Soydas T, Ekmekci CG, Yazici Guvercin AC, Kucuk OS, Sultuybek GK. Fas and microRNAs Variations as a Possible Risk for Behcet's Disease. J Clin Rheumatol. 2020. doi:10.1097/RHU.0000000000001254.
   PubMed Web of Science ®Google Scholar
• Kamal A, Elgengehy FT, Elawady Z, Fawzy NA, El Sisi O. Role of miR-146a rs2910164 and UTS2 rs228648 genetic variants in Behçet’s Disease. Immunol Invest. 2021;1–10. doi:10.1080/08820139.2021.1883647.
   PubMed Web of Science ®Google Scholar
• Park R, Lee WJ, Ji JD. Association between the three functional miR-146a single-nucleotide polymorphisms, rs2910164, rs57095329, and rs2431697, and autoimmune disease susceptibility: a meta-analysis. Autoimmunity. 2016;49:451–458. doi:10.3109/08916934.2016.1171854.
   PubMed Web of Science ®Google Scholar
• Stang A. Critical evaluation of the Newcastle-Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol. 2010;25:603–605. doi:10.1007/s10654-010-9491-z.
   PubMed Web of Science ®Google Scholar
• Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med. 2002;21:1539–1558. doi:10.1002/sim.1186.
   PubMed Web of Science ®Google Scholar
• DerSimonian R, Laird N. Meta-analysis in clinical trials. Control Clin Trials. 1986;7:177–188. doi:10.1016/0197-2456(86)90046-2.
   PubMed Web of Science ®Google Scholar
• Begg CB, Mazumdar M. Operating characteristics of a rank correlation test for publication bias. Biometrics. 1994;50:1088–1101. doi:10.2307/2533446.
   PubMed Web of Science ®Google Scholar
• Egger M, Davey Smith G, Schneider M, Minder C. Bias in meta-analysis detected by a simple, graphical test. BMJ. 1997;315:629–634. doi:10.1136/bmj.315.7109.629.
   PubMed Web of Science ®Google Scholar
• Aalaei-Andabili SH, Rezaei N. MicroRNAs (MiRs) precisely regulate immune system development and function in immunosenescence process. Int Rev Immunol. 2016;35:57–66. doi:10.3109/08830185.2015.1077828.
   PubMed Web of Science ®Google Scholar
• Pivarcsi A, Stahle M, Sonkoly E. Genetic polymorphisms altering microRNA activity in psoriasis–a key to solve the puzzle of missing heritability? Exp Dermatol. 2014;23:620–624. doi:10.1111/exd.12469.
   PubMed Web of Science ®Google Scholar
• Pauley KM, Chan EK. MicroRNAs and their emerging roles in immunology. Ann N Y Acad Sci. 2008;1143:226–239. doi:10.1196/annals.1443.009.
   PubMed Web of Science ®Google Scholar
• Saba R, Sorensen DL, Booth SA. MicroRNA-146a: a dominant, negative regulator of the innate immune response. Front Immunol. 2014;5:578. doi:10.3389/fimmu.2014.00578.
   PubMed Web of Science ®Google Scholar
• Iwai N, Naraba H. Polymorphisms in human pre-miRNAs. Biochem Biophys Res Commun. 2005;331:1439–1444. doi:10.1016/j.bbrc.2005.04.051.
   PubMed Web of Science ®Google Scholar
• Pedersen IM, Cheng G, Wieland S, et al. Interferon modulation of cellular microRNAs as an antiviral mechanism. Nature. 2007;449:919–U13. doi:10.1038/nature06205.
   PubMed Web of Science ®Google Scholar